On this episode, I was joined by Martin Van Trieste, Author of Protecting the Patient at All Costs: The Drug Watch Dogs and is the Former Chief Quality Officer at Amgen and Former CEO at Civica Rx.

Martin and I discuss:

- Protecting the Patient at All Costs

- Quality Leadership and being a Chief Quality Officer in Big Pharma

- Supply Chain Security

- Generic Drugs and Shortages

Martin Van Trieste is an accomplished entrepreneur, board governance expert, executive coach and biopharmaceutical executive. Martin Van Trieste is the Former President and CEO of Civica Rx.

Prior to joining Civica Rx, he worked with Amgen, a leading biotechnology company and also previously served as vice president of worldwide quality for Bayer Healthcare’s Biological Products Division and vice president of quality assurance for the Hospital Products Division for Abbott Laboratories.

Van Trieste has also taken on ventures of his own. He’s the founder of Rx-360, an international nonprofit organization that enhances patient safety by increasing security and quality in the biopharmaceutical supply chain.

He has also served as the chairman of the Parenteral Drug Association (PDA) Board of Directors and was honored with the 2020 Joseph B. Sprowls Lecturer award.